Using Days Alive and Out of Hospital as the Study Endpoint in Cardiovascular Heart Failure Clinical Trials [0.03%]
使用住院天数作为心血管临床试验终点指标研究心力衰竭患者疗效
Zachary R McCaw,Stephanie Armbruster,Lu Tian et al.
Zachary R McCaw et al.
Physician-Directed Patient Self-Management Using an Implantable IVC Congestion Sensor: Insights From FUTURE-HFII [0.03%]
使用植入式IVC充血传感器指导患者自我管理的医师方向性方案：FUTURE-HF II研究结果
Nir Uriel,Mandeep R Mehra,Barry R Greene et al.
Nir Uriel et al.
Background: Prior self-management strategies to prevent heart failure (HF) hospitalizations using symptoms and weight have shown limited effectiveness caused by delayed and nonspecific signals. Ambulatory congestion monit...
Viana Copeland,Boris Fishman,Shir Elimeleh et al.
Viana Copeland et al.
April Stempien-Otero
April Stempien-Otero
Leslie T Cooper Jr,Cristina Basso,Marc K Halushka et al.
Leslie T Cooper Jr et al.
The Left Atrium: Heart Failure's Silent "Memory" Across the Spectrum of Functional Mitral Regurgitation [0.03%]
左心房：功能性二尖瓣反流谱系中心力衰竭的沉默“记忆”
Sebastiaan Dhont,Philippe B Bertrand,Alessandro Malagoli
Sebastiaan Dhont
Exercise-Induced Versus Resting Left Atrial Hypertension: 2 Phases or 2 Faces of HFpEF? [0.03%]
运动诱发的左心房高血压与静息状态下的左心房高血压：HFpEF的两个阶段还是两种表现？
Karl-Philipp Rommel,Mark N Belkin
Karl-Philipp Rommel
Secondary Mitral Regurgitation Trajectories and Prognosis With Intensification of Guideline-Directed Medical Therapy in Heart Failure [0.03%]
心力衰竭患者指南指导的药物强化治疗对二尖瓣反流轨迹和预后的影响
Cristina Ferrero,Pau Codina,Josep Lupón et al.
Cristina Ferrero et al.
Background: Secondary mitral regurgitation (SMR) frequently accompanies heart failure with reduced ejection fraction (HFrEF) and may regress with guideline-directed medical therapy (GDMT). However, real-world data on SMR ...
Kidney Disease and Heart Failure: Recent Advances and Current Challenges: Conclusions From a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference [0.03%]
肾脏疾病与心力衰竭：近期进展和当前挑战：肾病：改善全球结局(KDIGO)争议会议结论
Carolyn S P Lam,Biykem Bozkurt,David Z I Cherney et al.
Carolyn S P Lam et al.
Heart failure (HF) and chronic kidney disease (CKD) frequently coexist, which elevates the risks of hospitalization, disease progression, and death. Despite advances in treating each condition independently, many challenges remain in diagno...
Practice Guideline
JACC. Heart failure. 2026 Mar 6:102943. DOI:10.1016/j.jchf.2026.102943 2026
Empagliflozin in De Novo vs Acute Decompensated Chronic Heart Failure: A Prespecified Analysis From EMPULSE [0.03%]
恩格列净用于初始心力衰竭与急性失代偿性慢性心力衰竭的预设分析：EMPULSE试验结果
Christiane E Angermann,Teresa Gerhardt,Jonathan P Blatchford et al.
Christiane E Angermann et al.
Background: In EMPULSE (A Study to Test the Effect of Empagliflozin in Patients Who Are in Hospital for Acute Heart Failure), the sodium-glucose cotransporter 2 inhibitor empagliflozin improved clinical outcomes in patien...